Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders
- PMID: 26868367
- DOI: 10.1007/s10897-016-9933-1
Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders
Abstract
Due to the lack of empirical information on parental perceptions of primary results of whole exome sequencing (WES), we conducted a retrospective semi-structured interview with 19 parents of children who had undergone WES. Perceptions explored during the interview included factors that would contribute to parental empowerment such as: parental expectations, understanding of the WES and results, utilization of the WES information, and communication of findings to health/educational professionals and family members. Results of the WES had previously been communicated to families within a novel framework of clinical diagnostic categories: 5/19 had Definite diagnoses, 6/19 had Likely diagnoses, 3/19 had Possible diagnosis and 5/19 had No diagnosis. All parents interviewed expressed a sense of duty to pursue the WES in search of a diagnosis; however, their expectations were tempered by previous experiences with negative genetic testing results. Approximately half the parents worried that a primary diagnosis that would be lethal might be identified; however, the hope of a diagnosis outweighed this concern. Parents were accurately able to summarize their child's WES findings, understood the implications for recurrence risks, and were able to communicate these findings to family and medical/educational providers. The majority of those with a Definite/Likely diagnosis felt that their child's medical care was more focused, or there was a reduction in worry, despite the lack of a specific treatment. Irrespective of diagnostic outcome, parents recommended that follow-up visits be built into the process. Several parents expressed a desire to have all variants of unknown significance (VUS) reported to them so that they could investigate these themselves. Finally, for some families whose children had a Definite/Likely diagnosis, there was remaining frustration and a sense of isolation, due to the limited information that was available about the diagnosed rare disorders and the inability to connect to other families, suggesting that for families with rare genetic disorders, the diagnostic odyssey does not necessarily end with a diagnosis. Qualitative interviewing served a meaningful role in eliciting new information about parental motivations, expectations, and knowledge of WES. Our findings highlight a need for continued communication with families as we navigate the new landscape of genomic sequencing.
Keywords: Empowerment; Genetic counseling; Parental perspectives; Whole exome sequencing.
Similar articles
-
Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.J Genet Couns. 2016 Dec;25(6):1207-1214. doi: 10.1007/s10897-016-9958-5. Epub 2016 Apr 20. J Genet Couns. 2016. PMID: 27098417 Free PMC article.
-
Ending a Diagnostic Odyssey: Family Education, Counseling, and Response to Eventual Diagnosis.Pediatr Clin North Am. 2017 Feb;64(1):265-272. doi: 10.1016/j.pcl.2016.08.017. Pediatr Clin North Am. 2017. PMID: 27894449 Review.
-
Qualitative analysis of the needs of parents of children with rare genetic diseases, following their diagnosis obtained by whole-exome sequencing.J Genet Couns. 2025 Jun;34(3):e70015. doi: 10.1002/jgc4.70015. J Genet Couns. 2025. PMID: 40305385
-
Caregivers' perception of and experience with variants of uncertain significance from whole exome sequencing for children with undiagnosed conditions.J Genet Couns. 2019 Apr;28(2):304-312. doi: 10.1002/jgc4.1093. Epub 2019 Jan 24. J Genet Couns. 2019. PMID: 30680845
-
Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.Clin Genet. 2016 Mar;89(3):275-84. doi: 10.1111/cge.12654. Epub 2015 Sep 22. Clin Genet. 2016. PMID: 26283276 Free PMC article. Review.
Cited by
-
Parents' perceptions of personal utility of exome sequencing results.Genet Med. 2020 Apr;22(4):752-757. doi: 10.1038/s41436-019-0730-8. Epub 2019 Dec 20. Genet Med. 2020. PMID: 31857707 Free PMC article.
-
Shortened consent forms for genome-wide sequencing: Parent and provider perspectives.Mol Genet Genomic Med. 2020 Jul;8(7):e1254. doi: 10.1002/mgg3.1254. Epub 2020 May 8. Mol Genet Genomic Med. 2020. PMID: 32383361 Free PMC article.
-
What matters to parents? A scoping review of parents' service experiences and needs regarding genetic testing for rare diseases.Eur J Hum Genet. 2023 Aug;31(8):869-878. doi: 10.1038/s41431-023-01376-y. Epub 2023 Jun 12. Eur J Hum Genet. 2023. PMID: 37308600 Free PMC article.
-
Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples.J Genet Couns. 2022 Feb;31(1):59-70. doi: 10.1002/jgc4.1451. Epub 2021 Jun 11. J Genet Couns. 2022. PMID: 34115423 Free PMC article.
-
Writing the worlds of genomic medicine: experiences of using participatory-writing to understand life with rare conditions.Med Humanit. 2022 Jun;48(2):e4. doi: 10.1136/medhum-2021-012346. Epub 2022 Apr 13. Med Humanit. 2022. PMID: 35418508 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical